We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current YMTX market cap is 19.64M. The company's latest EPS is USD -1.3565 and P/E is -1.39.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | -2.13M | 281k | 5.16M | 0 | 0 |
| Operating Income | -24.29M | -6.49M | -980k | -3.99M | -4.27M |
| Net Income | -41.82M | -6.45M | 386k | -5.38M | -2.65M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 5M | 6.9M | 8.04M | 1.95M | 5.44M |
| Operating Income | -61.15M | -55.63M | -38.75M | -41.53M | -15.72M |
| Net Income | -59.13M | -50.79M | -39.5M | -63.41M | -14.1M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 17.44M | 13.05M | 17.5M | 10.71M | 10.28M |
| Total Liabilities | 12.87M | 13.11M | 9.89M | 7.82M | 7.22M |
| Total Equity | 4.57M | -56k | 7.61M | 2.89M | 3.06M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 84.72M | 114.84M | 62.93M | 17.44M | 10.28M |
| Total Liabilities | 22.35M | 58.63M | 39.44M | 12.87M | 7.22M |
| Total Equity | 62.38M | 56.21M | 23.5M | 4.57M | 3.06M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -19.03M | -4.94M | -11.91M | -12.13M | -16.21M |
| Investing | 9.27M | 285k | 303k | 331k | 331k |
| Financing | 11.81M | 750k | 6.23M | 6.22M | 8.47M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -53.22M | -17.94M | -48.92M | -19.03M | -16.21M |
| Investing | 46.07M | 31.04M | 3.09M | 9.27M | 331k |
| Financing | 3.36M | 55.54M | -1.03M | 11.81M | 8.47M |
| Market Cap | 19.64M |
| Price to Earnings Ratio | -1.39 |
| Price to Sales Ratio | 3.61 |
| Price to Cash Ratio | 3.4 |
| Price to Book Ratio | 6.42 |
| Dividend Yield | - |
| Shares Outstanding | 10.39M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.1 (5.29%) |
| Company Name | Yumanity Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.kinetabio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
